tirzepatide dose vs semaglutide Subcutaneously administered for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials | Diabetologia Switching Between Semaglutide and Tirzepatide:

Tirzepatide is a dual agonist that activates both the GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors

Tirzepatide 10 and 15 mg were associated with statistically greater reductions in waist circumference versus semaglutide (MD 4.81 and 5.32 cm, respectively) (Table 2 and Fig

They plateau on semaglutide and wonder if the "equivalent" tirzepatide dose would work better, without realizing no true equivalence exists

The risk is sacrificing science in favor of a narrative that may be compelling but is fragile

How can genetic testing help me decide on supplementation with Tirzepatide